<DOC>
	<DOCNO>NCT00470665</DOCNO>
	<brief_summary>The purpose study ass whether high-risk kidney transplant patient ( patient whose previous kidney transplant fail , high PRA lab test result African-American descent ) combination Rapamune Prograf steroid prevent acute rejection well Rapamune cyclosporine steroid .</brief_summary>
	<brief_title>Study Comparing Sirolimus/Prograf v Sirolimus/CsA High-Risk Renal Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Inclusion criterion : Patients AfricanAmerican descent patient history multiple transplant and/or patient high panel reactive antibody lab test renal transplant cadaveric donor , live unrelated donor livingrelated mismatched donor . Age &gt; = 13 year , weight &gt; = 40 kg Women must negative pregnancy test study entry Exclusion criterion Multiple organ transplant double kidney transplant ( pediatric enbloc double adult ) Active systemic infection , localize major infection know HIV Patients residual kidney function &gt; 20 mL/min</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
</DOC>